Alzamend Neuro Inc (ALZN)

Currency in USD
2.2000
-0.0500(-2.22%)
Closed·
After Hours
2.2499+0.0499(+2.27%)
·
ALZN Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Trading near 52-week Low
Fair Value
Day's Range
2.06002.2809
52 wk Range
2.0600135.5400
Key Statistics
Prev. Close
2.25
Open
2.11
Day's Range
2.06-2.2809
52 wk Range
2.06-135.54
Volume
103.62K
Average Volume (3m)
1.66M
1-Year Change
-93.05%
Book Value / Share
5.4
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
ALZN Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
180.0000
Upside
+8,081.82%
Members' Sentiments
Bearish
Bullish
ProTips
RSI suggests the stock is in oversold territory

Alzamend Neuro Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Alzamend Neuro Inc Company Profile

Alzamend Neuro, Inc., a clinical-stage biopharmaceutical company, focuses on developing various products for the treatment of neurodegenerative and psychiatric disorders. Its pipeline includes AL001, which delivers a therapeutic combination of lithium, proline, and salicylate for the treatment of Alzheimer’s, bi-polar disorder, post-traumatic stress disorder, major depressive disorder, other neurodegenerative diseases, and psychiatric disorders; and ALZN002, which uses a method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine to restore the ability of a patient’s immunological system to combat Alzheimer’s disease. Alzamend Neuro, Inc. was incorporated in 2016 and is headquartered in Atlanta, Georgia.

Compare ALZN to Peers and Sector

Metrics to compare
ALZN
Peers
Sector
Relationship
P/E Ratio
−1.2x−5.7x−0.5x
PEG Ratio
−0.01−0.110.00
Price/Book
1.6x3.3x2.6x
Price / LTM Sales
-9.3x3.2x
Upside (Analyst Target)
-166.3%45.7%
Fair Value Upside
Unlock−2.2%8.6%Unlock

Analyst Ratings

1 Buy
1 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 180.0000
(+8,081.82% Upside)

Earnings

Latest Release
Jul 22, 2025
EPS / Forecast
-2.43 / -0.59
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

ALZN Income Statement

People Also Watch

31.68
BMNR
-8.55%
0.039
NCNA
-9.32%
0.92
KLTO
-4.15%
14.7200
INKT
-2.90%
5.140
GVH
-8.87%

FAQ

What Stock Exchange Does Alzamend Neuro Trade On?

Alzamend Neuro is listed and trades on the Nasdaq Stock Exchange stock exchange.

What Is the Stock Symbol for Alzamend Neuro?

The stock symbol for Alzamend Neuro is "ALZN."

What Is the Alzamend Neuro Market Cap?

As of today, Alzamend Neuro market cap is 6.37M.

What Is Alzamend Neuro's Earnings Per Share (TTM)?

The Alzamend Neuro EPS (TTM) is -11.32.

From a Technical Analysis Perspective, Is ALZN a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Alzamend Neuro Stock Split?

Alzamend Neuro has split 3 times.

How Many Employees Does Alzamend Neuro Have?

Alzamend Neuro has 6 employees.

What is the current trading status of Alzamend Neuro (ALZN)?

As of 02 Aug 2025, Alzamend Neuro (ALZN) is trading at a price of 2.20, with a previous close of 2.25. The stock has fluctuated within a day range of 2.06 to 2.28, while its 52-week range spans from 2.06 to 135.54.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.